Episode
An Interview with Paul MacDonald, the Cofounder & Managing Director of Bio Innovations Midwest
- Podcast
- Iowa Tech Podcast
- Published
- Sep 9, 2025
- Duration seconds
- 1775
- Processing state
not_requested- Canonical source
- https://iowapodcast.com/paul-macdonald
Actions
POST https://stenobird.com/v1/public/podcasts/iowa-tech-podcast-7097920/episodes/an-interview-with-paul-macdonald-the-cofounder-managing-director-of-bio-innovations-midwest/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/iowa-tech-podcast-7097920/an-interview-with-paul-macdonald-the-cofounder-managing-director-of-bio-innovations-midwest.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of the Iowa Tech podcast, host Kaylee Williams dives into an insightful conversation with Paul MacDonald, co-founder and managing director of the Bio Innovations Midwest conference. Paul shares the origin story of the conference, which initially began in Europe as World Bio Markets before transitioning to Bio Innovations Europe. He discusses how the Nebraska Department of Economic Development played a crucial role in bringing the event to the Midwest. The podcast explores the unique format of Bio Innovations Midwest, emphasizing pre-arranged one-to-one meetings that facilitate meaningful connections between scientists, potential customers, partners, and investors, rather than the traditional lecture-heavy conference setup. Paul and Kaylee further discuss the importance of commercializing bio-based innovations to achieve price parity with fossil-derived products and the potential for these innovations to solve global sustainability challenges. As the conversation unfolds, Paul outlines the strategic expansion of Bio Innovations conferences to different parts of the world, including plans to rebrand Bio Innovations Midwest to Bio Innovations North America in 2026, and launch Bio Innovations APAC in Singapore. He highlights Singapore's role as a business hub in Asia and the partnership with Synergy, Singapore's synthetic biology department, as key reasons for this new endeavor. Throughout the episode, Paul emphasizes the importance of simplifying the bioeconomy for broader understanding and investment, categorizing the market into five groups: biodevelopers, community enablers, investors, brands and buyers, and suppliers. The podcast encourages listeners to attend the upcoming Bio Innovations Midwest conference, offering a platform for innovators to connec…